Compare NNOX & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNOX | STXS |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 182.3M |
| IPO Year | 2019 | 2004 |
| Metric | NNOX | STXS |
|---|---|---|
| Price | $2.16 | $1.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $5.00 | $4.00 |
| AVG Volume (30 Days) | ★ 970.0K | 414.3K |
| Earning Date | 04-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | $20.19 | $28.22 |
| Revenue Next Year | $137.69 | $30.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.11 | $1.74 |
| 52 Week High | $5.72 | $3.59 |
| Indicator | NNOX | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 40.47 | 51.77 |
| Support Level | $2.11 | $1.97 |
| Resistance Level | $2.66 | $1.99 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 4.23 | 54.55 |
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.